Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

被引：120

作者：

Nagel, Gabriele ^{[1
]}

Weber, D. ^{[2
]}

Fromm, E. ^{[1
]}

Erhardt, S. ^{[1
]}

Luebbert, M. ^{[3
]}

Fiedler, W. ^{[4
]}

Kindler, T. ^{[5
]}

Krauter, J. ^{[6
]}

Brossart, P. ^{[7
]}

Kuendgen, A. ^{[8
]}

Salih, H. R. ^{[9
]}

Westermann, J. ^{[10
]}

Wulf, G. ^{[11
]}

Hertenstein, B. ^{[12
]}

Wattad, M. ^{[13
]}

Goetze, K. ^{[14
]}

Kraemer, D. ^{[15
]}

Heinicke, T. ^{[16
]}

Girschikofsky, M. ^{[17
]}

Derigs, H. G. ^{[18
]}

Horst, H. A. ^{[19
]}

Rudolph, C. ^{[2
]}

Heuser, M. ^{[20
]}

Goehring, G. ^{[21
]}

Teleanu, V. ^{[2
]}

Bullinger, L. ^{[2
]}

Thol, F. ^{[20
]}

Gaidzik, V. I. ^{[2
]}

Paschka, P. ^{[2
]}

Doehner, K. ^{[2
]}

Ganser, A. ^{[20
]}

Doehner, Hartmut ^{[2
]}

Schlenk, R. F. ^{[2
,22
]}

机构：

[1] Univ Ulm, Inst Epidemiol & Med Biometry, Helmholtzstr 22, D-89081 Ulm, Germany

[2] Univ Hosp Ulm, Dept Internal Med 3, Albert Einstein Allee 23, D-89081 Ulm, Germany

[3] Univ Hosp Freiburg, Dept Internal Med 1, Fac Med, Freiburg, Germany

[4] Univ Hosp Hamburg Eppendorf, Dept Internal Med 2, Hamburg, Germany

[5] Univ Med Ctr Mainz, Dept Internal Med 3, Mainz, Germany

[6] Hosp Braunschweig, Dept Internal Med 3, Braunschweig, Germany

[7] Univ Hosp Bonn, Dept Internal Med 3, Bonn, Germany

[8] Univ Hosp Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[9] Univ Hosp Tubingen, Dept Internal Med 2, Tubingen, Germany

[10] Charite Campus Virchow Clin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[11] Univ Hosp Gottingen, Dept Hematol & Oncol, Gottingen, Germany

[12] Hosp Bremen Mitte, Dept Internal Med 1, Bremen, Germany

[13] Hosp Essen Werden, Dept Hematol & Oncol, Essen, Germany

[14] Univ Hosp, Klinikum Rechts Isar, Dept Internal Med 3, Munich, Germany

[15] Hosp Oldenburg, Dept Hematol & Oncol, Oldenburg, Germany

[16] Univ Hosp Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany

[17] Hosp Elisabethinen Linz, Dept Hematol & Oncol, Linz, Austria

[18] Hosp Frankfurt Hoechst, Dept Internal Med 3, Frankfurt, Germany

[19] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[20] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[21] Hannover Med Sch, Inst Human Genet, Hannover, Germany

[22] Natl Ctr Tumor Dis, NCT Trial Ctr, Heidelberg, Germany

来源：

ANNALS OF HEMATOLOGY | 2017年 / 96卷 / 12期

关键词：

Epidemiology; Genetics; Older age; AML; Registry; INTERNATIONAL EXPERT PANEL; OLDER PATIENTS; CELL TRANSPLANTATION; SURVIVAL; ADULTS; MUTATIONS; CANCER; RECOMMENDATIONS; CLASSIFICATION; MALIGNANCIES;

D O I：

10.1007/s00277-017-3150-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe genetic and clinical characteristics of acute myeloid leukemia (AML) patients according to age from an academic population-based registry. Adult patients with newly diagnosed AML at 63 centers in Germany and Austria were followed within the AMLSG BiO registry (NCT01252485). Between January 1, 2012, and December 31, 2014, data of 3525 patients with AML (45% women) were collected. The median age was 65 years (range 18-94). The comparison of age-specific AML incidence rates with epidemiological cancer registries revealed excellent coverage in patients < 70 years old and good coverage up to the age of 80. The distribution according to the European LeukemiaNet (ELN) risk categorization from 2010 was 20% favorable, 31% intermediate-1, 28% intermediate-2, and 21% adverse. With increasing age, the relative but not the absolute prevalence of patients with ELN favorable and intermediate-1 risk (p < 0.001), with activating FLT3 mutations (p < 0.001), with ECOG performance status < 2 (p < 0.001), and with HCT-CI comorbidity index < 3 (p < 0.001) decreased. Regarding treatment, obesity and favorable risk were associated with an intensive treatment, whereas adverse risk, higher age, and comorbidity index > 0 were associated with non-intensive treatment or best supportive care. The AMLSG BiO registry provides reliable population-based distributions of genetic, clinical, and treatment characteristics according to age.

引用

页码：1993 / 2003

页数：11

共 35 条

[1] [Anonymous], 1975, SEER Cancer Statistics Review
[2] Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study
Becker, Heiko
Marcucci, Guido
Maharry, Kati
Radmacher, Michael D.
Mrozek, Krzysztof
Margeson, Dean
Whitman, Susan P.
Wu, Yue-Zhong
Schwind, Sebastian
Paschka, Peter
Powell, Bayard L.
Carter, Thomas H.
Kolitz, Jonathan E.
Wetzler, Meir
Carroll, Andrew J.
Baer, Maria R.
Caligiuri, Michael A.
Larson, Richard A.
Bloomfield, Clara D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 596 - 604
[3] Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia
Brunner, Andrew M.
Sadrzadeh, Hossein
Feng, Yang
Drapkin, Benjamin J.
Ballen, Karen K.
Attar, Eyal C.
Amrein, Philip C.
McAfee, Steven L.
Chen, Yi-Bin
Neuberg, Donna S.
Fathi, Amir T.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (08) : 642 - 646
[4] Bullinger L, 2017, J CLIN ONCO IN PRESS
[5] Therapeutic Advances in Acute Myeloid Leukemia
Burnett, Alan
Wetzler, Meir
Loewenberg, Bob
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (05) : 487 - 494
[6] Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012
Dinmohamed, A. G.
Visser, O.
van Norden, Y.
Blijlevens, N. M. A.
Cornelissen, J. J.
Huls, G. A.
Huijgens, P. C.
Sonneveld, P.
van de Loosdrecht, A. A.
Ossenkoppele, G. J.
Lowenberg, B.
Jongen-Lavrencic, M.
[J]. LEUKEMIA, 2016, 30 (01) : 24 - 31
[7] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Doehner, Hartmut
Estey, Elihu
Grimwade, David
Amadori, Sergio
Appelbaum, Frederick R.
Buechner, Thomas
Dombret, Herve
Ebert, Benjamin L.
Fenaux, Pierre
Larson, Richard A.
Levine, Ross L.
Lo-Coco, Francesco
Naoe, Tomoki
Niederwieser, Dietger
Ossenkoppele, Gert J.
Sanz, Miguel
Sierra, Jorge
Tallman, Martin S.
Tien, Hwei-Fang
Wei, Andrew H.
Lowenberg, Bob
Bloomfield, Clara D.
[J]. BLOOD, 2017, 129 (04) : 424 - 447
[8] Acute Myeloid Leukemia
Doehner, Hartmut
Weisdorf, Daniel J.
Bloomfield, Clara D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (12) : 1136 - 1152
[9] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Doehner, Hartmut
Estey, Elihu H.
Amadori, Sergio
Appelbaum, Frederick R.
Buechner, Thomas
Burnett, Alan K.
Dombret, Herve
Fenaux, Pierre
Grimwade, David
Larson, Richard A.
Lo-Coco, Francesco
Naoe, Tomoki
Niederwieser, Dietger
Ossenkoppele, Gert J.
Sanz, Miguel A.
Sierra, Jorge
Tallman, Martin S.
Loewenberg, Bob
Bloomfield, Clara D.
[J]. BLOOD, 2010, 115 (03) : 453 - 474
[10] Precision oncology for acute myeloid leukemia using a knowledge bank approach
Gerstung, Moritz
Papaemmanuil, Elli
Martincorena, Inigo
Bullinger, Lars
Gaidzik, Verena I.
Paschka, Peter
Heuser, Michael
Thol, Felicitas
Bolli, Niccolo
Ganly, Peter
Ganser, Arnold
McDermott, Ultan
Dohner, Konstanze
Schlenk, Richard F.
Dohner, Hartmut
Campbell, Peter J.
[J]. NATURE GENETICS, 2017, 49 (03) : 332 - 340

← 1 2 3 4 →